home · filing · 0000010795-21-000079
8-K filed October 22, 2021, 7:59 PM ET
ticker BDX
CIK 0000010795
leadership
confidence high
sentiment neutral
materiality 0.20
BD elects Dr. Carrie L. Byington to Board of Directors
BECTON DICKINSON & CO
Dr. Byington elected to BD Board effective October 21, 2021.
She will serve on the Audit Committee and Quality and Regulatory Committee.
Board determined Dr. Byington is independent under NYSE rules.
She receives prorated restricted stock units valued at $54,969 until 2022 annual meeting.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Carrie L. Byington
Director
BDX ·
BECTON DICKINSON & CO
Effective 2021-10-21
Filed October 22, 2021, 7:59 PM ET
On October 21, 2021, Carrie L. Byington, M.D. was elected to the Board of Directors of Becton, Dickinson and Company (“BD”).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Carrie L. Byington was elected as Director at BECTON DICKINSON & CO.
Action elected
Role Director
Exact text from the filing
On October 21, 2021, Carrie L. Byington, M.D. was elected to the Board of Directors of Becton, Dickinson and Company (“BD”).
View on SEC.gov
Source: SEC EDGAR
accession 0000010795-21-000079
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.